Related Experiment Videos
Evidence for the benefit of targeted proteomics in the era of the "big data" approach
The American Journal of Managed Care
|January 31, 2018
Abstract:
The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.